NEW YORK CITY, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Shanghai Henlius Biotech, Inc. (“Henlius”) announced FDA acceptance of the Biologics License Application (BLA) for ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Denali Therapeutics (DNLI) announced the primary analysis of the Phase 1/2 study in 47 participants with Hunter syndrome in the 24-week ...

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

BIS issued an Interim Final Rule that amends the Export Administration Regulation (EAR) to address dual use export ...

Also, transgender, queer, and intersex people were removed from State Department travel advisories. What was previously an advisory page for LGBTQI+ travelers has been renamed LGB Travel Information.

This article was originally published in our sister publication, The Stranger.—eds] When Joe Biden was President, trans ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Ultragenyx announces new safety and efficacy data from its pivotal study of its investigational candidate, UX111, for ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...